TY  - EJOU
AU  - ZHAO, XUNAN 
AU  - MAGO, EMMANUEL 
AU  - WENG, DAN 

TI  - Role of RIPK1 in the pathogenesis of acute respiratory distress syndrome
T2  - BIOCELL

PY  - 2023
VL  - 47
IS  - 10
SN  - 1667-5746

AB  - Acute respiratory distress syndrome (ARDS) is a life-threatening pulmonary disease typically caused by microbial infections, trauma, inhalation of harmful gases, and other factors. It is characterized by an inflammation in the lungs and increased alveolar permeability, leading to pulmonary edema and consequently, a low oxygen supply or hypoxemia. ARDS is responsible for 1 in 10 admissions to intensive care units, and the mortality rate for patients with severe ARDS is as high as 46%. Extensive efforts have been devoted to investigating the pathological mechanisms of ARDS to develop new effective clinical strategies. Recent studies have reported that receptor-interacting serine/threonine kinase 1 (RIPK1) is involved in the pathogenesis of ARDS. RIPK1 is a critical mediator of programmed cell death and inflammation. Growing evidence suggests that RIPK1 plays a role in the pathogenesis of different inflammatory diseases and serves as a promising pharmaceutical target. This review summarizes and sheds some light on the recent findings regarding the role of RIPK1 and related molecules in the pathogenesis of ARDS.
KW  - ARDS; ALI; RIPK1; Necroptosis; Inflammation

DO  - 10.32604/biocell.2023.030570